S&P Equity Research downgrades Ceradyne (Nasdaq: CRDN) from Buy to Hold. Price target $48.

This article: 78 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE